Redchenko, I., Cappuccini, F., Pollock, E., Bryant, R., Carter, L., Verrill, C., . . . Hill, A. (2018). VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer. American Society of Clinical Oncology.
Dyfyniad Arddull ChicagoRedchenko, I., et al. VANCE: First-in-human Phase I Study of a Novel ChAdOx1-MVA 5T4 Vaccine in Low and Intermediate Risk Prostate Cancer. American Society of Clinical Oncology, 2018.
Dyfyniad MLARedchenko, I., et al. VANCE: First-in-human Phase I Study of a Novel ChAdOx1-MVA 5T4 Vaccine in Low and Intermediate Risk Prostate Cancer. American Society of Clinical Oncology, 2018.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.